Xylox-2.5 Tablets (Letrozole Tablets USP 2.5 mg)

₦8,000.00

In stock

  • Contains Letrozole USP 2.5 mg per tablet
  • Prescription-only medication
  • Manufactured by Bafna Pharmaceuticals Ltd.
  • Pack contains 28 film-coated tablets (2 Ă— 14)
  • Helps reduce estrogen production in the body
  • Used in the treatment of hormone receptor-positive breast cancer
  • May be prescribed by fertility specialists for ovulation induction
  • Oral tablet for convenient daily administration
  • Manufactured according to USP quality standards
  • Suitable only under medical supervision

Xylox-2.5 Tablets contain Letrozole USP 2.5 mg, a prescription-only aromatase inhibitor primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Manufactured by Bafna Pharmaceuticals Ltd., India, each pack contains 28 film-coated tablets (2 Ă— 14 tablets) for oral administration. The product is registered for prescription use and is marketed in several countries, including Nigeria.

Letrozole works by inhibiting the aromatase enzyme, significantly reducing the body’s production of estrogen. Since certain breast cancers rely on estrogen to grow, lowering estrogen levels helps slow or stop the growth of hormone-sensitive cancer cells. Xylox-2.5 Tablets are commonly prescribed as adjuvant therapy following surgery, as extended adjuvant therapy after tamoxifen treatment, or for advanced and metastatic breast cancer in postmenopausal women.

In reproductive medicine, letrozole is also widely prescribed off-label by fertility specialists to induce ovulation in women with ovulatory disorders, particularly those with polycystic ovary syndrome (PCOS). Clinical guidelines increasingly recognize letrozole as a first-line ovulation induction therapy for many women with PCOS, although this use should only be under the supervision of a qualified healthcare professional.

Xylox-2.5 Tablets should only be taken exactly as prescribed by a physician. The dosage and duration vary depending on the medical condition being treated. Common side effects may include hot flashes, headache, fatigue, dizziness, joint pain, muscle pain, and increased sweating. Long-term treatment may affect bone mineral density, making regular medical monitoring important during therapy.

This medicine is not suitable during pregnancy or breastfeeding and should only be used under medical supervision. Patients should always discuss their complete medical history, including liver disease, osteoporosis, or high cholesterol, with their healthcare provider before starting treatment.

Additional information

Weight 0.1 kg
Be the first to review “Xylox-2.5 Tablets (Letrozole Tablets USP 2.5 mg)”

Your email address will not be published. Required fields are marked *

Reviews

There are no reviews yet.

Main Menu

Xylox-2.5 Tablets (Letrozole Tablets USP 2.5 mg)

Xylox-2.5 Tablets (Letrozole Tablets USP 2.5 mg)

₦8,000.00

Add to cart